The jab is the third emergency use granted in the Gulf country after Sinopharm and Pfizer / BioNtech in China.
Bahrain has granted emergency authorization for the use of a coronavirus vaccine produced by the British pharmaceutical company AstraZeneca in collaboration with the University of Oxford.
The National Health Regulatory Authority (NHRA) approved the vaccine on Monday, according to the Bahrain National News Agency.
The approval was based on a study conducted by the NHRA in conjunction with the Health Ministry’s Clinical Research Committee and Immunization Committee, the Bahrain News Agency reported.
With a population of 1.6 million, the small country has reported more than 99,800 cases and 367 deaths, according to a count from Johns Hopkins University.
The Oxford-AstraZeneca shot is the third to be approved in the Gulf country. Bahrain has already given the green light for emergency use to a Chinese-made vaccine produced by Sinopharm, and it was the second country in the world to approve the Pfizer / BioNtech jab.
AstraZeneca, whose vaccine trials have shown 70.4% efficiency rate, has come under increasing scrutiny since last week, when it informed European Union officials that it would cut deliveries by 60% in the first quarter of the year due to production problems.
Bahrain’s news agency did not say how much or when the vaccine was delivered. The blow must be given in two shots, 28 days apart.